LitCovid-sample-Enju  

PMC:7253482 / 3023-3291 JSONTXT 20 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T461 0-4 DT denotes This
T462 5-15 NN denotes phenomenon
T463 16-18 IN denotes of
T464 19-25 JJ denotes immune
T465 26-33 NN denotes evasion
T466 34-36 IN denotes by
T467 37-46 JJ denotes molecular
T468 47-54 NN denotes mimicry
T469 55-58 CC denotes and
T470 59-65 NN denotes glycan
T471 66-75 NN denotes shielding
T472 76-79 VBZ denotes has
T473 80-84 VBN denotes been
T474 85-89 RB denotes well
T475 90-103 VBN denotes characterised
T476 104-110 IN denotes across
T477 111-116 JJ denotes other
T478 117-122 JJ denotes viral
T479 123-136 NNS denotes glycoproteins
T480 136-137 -COMMA- denotes ,
T481 138-142 JJ denotes such
T482 143-145 IN denotes as
T483 146-151 NN denotes HIV-1
T484 152-160 NN denotes envelope
T485 161-168 NN denotes protein
T486 169-170 -LRB- denotes (
T487 170-173 NN denotes Env
T488 173-174 -RRB- denotes )
T489 174-179 CD denotes 19–21
T490 179-180 -COMMA- denotes ,
T491 181-190 NN denotes influenza
T492 191-204 NN denotes hemagglutinin
T493 205-206 -LRB- denotes (
T494 206-208 NN denotes HA
T495 208-209 -RRB- denotes )
T496 209-214 CD denotes 22,23
T497 215-218 CC denotes and
T498 219-224 NNP denotes Lassa
T499 225-230 NN denotes virus
T500 231-243 NN denotes glycoprotein
T501 244-251 NN denotes complex
T502 252-253 -LRB- denotes (
T503 253-257 NN denotes LASV
T504 258-261 NN denotes GPC
T505 261-262 -RRB- denotes )
T506 262-267 CD denotes 24–26
R458 T462 T461 arg1Of phenomenon,This
R459 T462 T463 arg1Of phenomenon,of
R460 T465 T463 arg2Of evasion,of
R461 T465 T464 arg1Of evasion,immune
R462 T462 T466 arg1Of phenomenon,by
R463 T469 T466 arg2Of and,by
R464 T468 T467 arg1Of mimicry,molecular
R465 T468 T469 arg1Of mimicry,and
R466 T471 T469 arg2Of shielding,and
R467 T471 T470 arg1Of shielding,glycan
R468 T462 T472 arg1Of phenomenon,has
R469 T475 T472 arg2Of characterised,has
R470 T462 T473 arg1Of phenomenon,been
R471 T475 T473 arg2Of characterised,been
R472 T475 T474 arg1Of characterised,well
R473 T462 T475 arg2Of phenomenon,characterised
R474 T475 T476 arg1Of characterised,across
R475 T479 T476 arg2Of glycoproteins,across
R476 T479 T477 arg1Of glycoproteins,other
R477 T479 T478 arg1Of glycoproteins,viral
R478 T479 T480 arg1Of glycoproteins,","
R479 T482 T481 arg1Of as,such
R480 T479 T482 arg1Of glycoproteins,as
R481 T497 T482 arg2Of and,as
R482 T485 T483 arg1Of protein,HIV-1
R483 T485 T484 arg1Of protein,envelope
R484 T492 T485 arg1Of hemagglutinin,protein
R485 T485 T486 arg1Of protein,(
R486 T487 T486 arg2Of Env,(
R487 T488 T486 arg3Of ),(
R488 T485 T489 arg1Of protein,19–21
R489 T485 T490 arg1Of protein,","
R490 T491 T490 arg2Of influenza,","
R491 T492 T491 arg1Of hemagglutinin,influenza
R492 T492 T493 arg1Of hemagglutinin,(
R493 T494 T493 arg2Of HA,(
R494 T495 T493 arg3Of ),(
R495 T492 T496 arg1Of hemagglutinin,"22,23"
R496 T492 T497 arg1Of hemagglutinin,and
R497 T501 T497 arg2Of complex,and
R498 T501 T498 arg1Of complex,Lassa
R499 T501 T499 arg1Of complex,virus
R500 T501 T500 arg1Of complex,glycoprotein
R501 T501 T502 arg1Of complex,(
R502 T504 T502 arg2Of GPC,(
R503 T505 T502 arg3Of ),(
R504 T504 T503 arg1Of GPC,LASV
R505 T501 T506 arg1Of complex,24–26